CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Planned sale Director sold 73,730 shares at an average $243.93 ($17,984,804)
- 4 Planned sale Director sold 11,000 shares at an average $257.48 ($2,832,335)
- 4 Planned sale Director sold 32,489 shares at an average $252.85 ($8,214,998)
- 4 Planned sale Director sold 32,489 shares at an average $252.97 ($8,218,630)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 10-K Report Annual Report
Page 14 of 62 · 1,224 filings